---
figid: PMC9616118__fmed-09-920062-g009
figtitle: Meritorious integrated medical regimen for hepatic fibrosis and its complications
  via the systematic review and meta-analysis for Dahuang Zhechong pill-based therapy
organisms:
- NA
pmcid: PMC9616118
filename: fmed-09-920062-g009.jpg
figlink: /pmc/articles/PMC9616118/figure/F9/
number: F9
caption: The metabolism of Dahuang Zhechong pill (DHZCP) in treating hepatic fibrosis
  according to the reported studies. In the molecular mechanism diagram (the lowest
  picture), arrows with the same color indicate the same signaling pathway.
papertitle: A meritorious integrated medical regimen for hepatic fibrosis and its
  complications via the systematic review and meta-analysis for Dahuang Zhechong pill-based
  therapy.
reftext: Zhen Ye, et al. Front Med (Lausanne). 2022;9:920062.
year: '2022'
doi: 10.3389/fmed.2022.920062
journal_title: Frontiers in Medicine
journal_nlm_ta: Front Med (Lausanne)
publisher_name: Frontiers Media S.A.
keywords: Dahuang Zhechong pill | hepatic fibrosis | therapy | systematic review |
  meta-analysis
automl_pathway: 0.9474785
figid_alias: PMC9616118__F9
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9616118__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9616118__fmed-09-920062-g009.html
  '@type': Dataset
  description: The metabolism of Dahuang Zhechong pill (DHZCP) in treating hepatic
    fibrosis according to the reported studies. In the molecular mechanism diagram
    (the lowest picture), arrows with the same color indicate the same signaling pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - SERPINB4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - MYD88
  - SHH
  - BAMBI
  - TLR4
  - TGFB1
  - TGFB2
  - TGFB3
  - FUT1
  - SMO
  - SMOX
---
